RxDoctor Payments Data

Jacky Yeung, MD

Neurological Surgery · New Haven, CTNPI 1326314568

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (45.8%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Elliquence, LLC accounts for 75.0% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $32,063, 6.6 times the $4,875 reported in 2021.

$50,381in general payments, 2019–2025

Across 123 payments — averaging $409.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Elliquence, LLC$38K
  • Globus Medical$4K
  • Medtronic$4K
  • Omniscient Neurotechnology America Ltd$1K
  • Aesculap Implant Systems, LLC$1K
  • Stryker$1K
  • plus $2K from 8 others

What the payments were for

  • Consulting fees$18,00036%
  • Speaking & faculty fees$4,0008%
  • Travel & lodging$23,07646%
  • Food & beverage$5,30511%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$50,381 in reported general payments places this provider in the 80th percentile of 94 neurological surgery providers in Connecticut.

See all neurological surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$70,439
Medicare patients
163
Services billed
301

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin16$522
Gabapentin12$161
Cyclobenzaprine Hcl22$155
Methylprednisolone18$110
Levetiracetam13$103
Hydromorphone Hcl13$78
Oxycodone Hcl20$58

Paid to pharmacies, not to this prescriber.

Other neurological surgery in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →